Abstract
The group of neuroectodermal and melanocytic tumors includes three malignant tumor types: sinonasal melanoma, olfactory neuroblastoma, and Ewing sarcoma. These tumors are often difficult to characterize, due to the overlap of their histologic features and immunohistochemical profiles with other entities. Olfactory neuroblastoma is a unique tumor type that characteristically originates in the superior nasal cavity, involving the cribriform plate of the ethmoid sinus, part of the superior turbinate (concha), or the superior half of the nasal septum. The prognosis depends on the stage, which is assigned according to the Kadish system, and on histologic grading, which is assigned according to the Hyams criteria.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cove H. Melanosis, melanocytic hyperplasia, and primary malignant melanoma of the nasal cavity. Cancer. 1979;44:1424–33.
Hofbauer GF, Böni R, Simmen D, Mihic D, Nestle FO, Burg G, Dummer R. Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis. Melanoma Res. 2002;12:77–82.
Clifton N, Harrison L, Bradley PJ, Jones NS. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol. 2011;125:479–85.
Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol. 2003;27:594–611.
Takeshita H, Miwa T, Furukawa M. Osteocartilaginous differentiation of mucosal melanoma in the sinonasal cavity. Ann Otol Rhinol Laryngol. 2002;111:1112–5.
Lee H, Torres FX, McLean SA, Chen R, Lee MW. Immunophenotypic heterogeneity of primary sinonasal melanoma with aberrant expression of neuroendocrine markers and calponin. Appl Immunohistochem Mol Morphol. 2011;19:48–53.
Safadi RA, Bader DH, Abdullah NY, Sughhayer MA. Immunohistochemical expression of keratins 6, 7, 8, 14, 16, 18, 19, and MNF-116 pancytokeratin in primary and metastatic melanoma of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:510–9.
Smith SM, Schmitt AC, Carrau RL, Iwenofu OH. Primary sinonasal mucosal melanoma with aberrant diffuse and strong desmin reactivity: a potential diagnostic pitfall! Head Neck Pathol. 2015;9:165–71.
Zebary A, Jangard M, Omholt K, Ragnarsson-Olding B, Hansson J. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases. Br J Cancer. 2013;109:559–64.
Wroblewska JP, Mull J, Wu CL, et al. SF3B1, NRAS, KIT, and BRAF mutation; CD117 and cMYC expression; and tumoral pigmentation in Sinonasal melanomas: an analysis with newly found molecular alterations and some population-based molecular differences. Am J Surg Pathol. 2019;43:168–77.
Cosgarea I, Ugurel S, Sucker A, et al. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations. Oncotarget. 2017;8:40683–92.
Hintzsche JD, Gorden NT, Amato CM, et al. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res. 2017;27:189–99.
Amit M, Tam S, Abdelmeguid AS, et al. Mutation status among patients with sinonasal mucosal melanoma and its impact on survival. Br J Cancer. 2017;116:1564–71.
Turri-Zanoni M, Medicina D, Lombardi D, et al. Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck. 2012;35(8):1066–77.
Franchi A, Alos L, Gale N, et al. Expression of p16 in sinonasal malignant melanoma. Virchows Arch. 2006;449:667–72.
Kardon DE, Thompson LD. Sinonasal mucosal malignant melanoma: report of an unusual case mimicking schwannoma. Ann Diagn Pathol. 2000;4:303–7.
Moreno MA, Roberts DB, Kupferman ME, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer. 2010;116:2215–23.
Prasad ML. Update on pigmented lesions of the sinonasal tract. Head Neck Pathol. 2007;1:50–4.
Khan MN, Kanumuri VV, Raikundalia MD, et al. Sinonasal melanoma: survival and prognostic implications based on site of involvement. Int Forum Allergy Rhinol. 2014;4:151–5.
Trapp TK, Fu YS, Calcaterra TC. Melanoma of the nasal and paranasal sinus mucosa. Arch Otolaryngol Head Neck Surg. 1987;113:1086–9.
Theilgaard SA, Buchwald C, Ingeholm P, et al. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol. 2003;123:433–9.
Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population based data. Head Neck. 2012;34:877–85.
Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133:276–80.
Kunc M, Gabrych A, Czapiewski P, Sworczak K. Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol (Pozn). 2015;19:6–16.
Ng HK, Poon WS, Poon CY, South JR. Intracranial olfactory neuroblastoma mimicking carcinoma: report of two cases. Histopathology. 1988;12:393–403.
Banerjee AK, Sharma BS, Vashista RK, Kak VK. Intracranial olfactory neuroblastoma: evidence for olfactory epithelial origin. J Clin Pathol. 1992;45:299–302.
Curtis JL, Rubinstein LJ. Pigmented olfactory neuroblastoma: a new example of melanotic neuroepithelial neoplasm. Cancer. 1982;49:2136–43.
Bishop JA, Thompson LD, Cardesa A, et al. Rhabdomyoblastic differentiation in head and neck malignancies other than rhabdomyosarcoma. Head Neck Pathol. 2015;9:507–18.
Meyer C, Hamersley ERS, Manosalva RE, Torske K, McIntyre N, Mitchell A. Olfactory neuroblastoma with divergent differentiation: an unusual histologic finding in a rare tumor. Head Neck Pathol. 2017;11:531–6.
Hyams VJ, Batsakis JG, Michaels L. Tumors of the upper respiratory tract and ear. Armed forces Institute of Pathology Fascicles, 2nd series. Washington: American Registry of Pathology Press; 1988.
Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in esthesioneuroblastoma survival. A population-based analysis. JAMA Otolaryngol Head Neck Surg. 2014;140:1124–9.
Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, Harner SG, VandenBerg SR. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer. 1995;76:4–19.
Frierson HF Jr, Ross GW, Mills SE, Frankfurter A. Olfactory neuroblastoma. Additional immunohistochemical characterization. Am J Clin Pathol. 1990;94:547–53.
Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol. 2011;35:1786–93.
Taggart MW, Hanna EY, Gidley P, Weber RS, Bell D. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol. 2015;19:154–6.
Min KW. Usefulness of electron microscopy in the diagnosis of “small” round cell tumors of the sinonasal region. Ultrastruct Pathol. 1995;19:347–63.
López-Hernández A, Vivanco B, Franchi A, et al. Genetic profiling of poorly differentiated sinonasal tumours. Sci Rep. 2018;8:3998.
Guled M, Myllykangas S, Frierson HF Jr, et al. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol. 2008;21:770–8.
Lazo de la Vega L, McHugh JB, Cani AK, et al. Comprehensive molecular profiling of olfactory neuroblastoma identifies potentially targetable FGFR3 amplifications. Mol Cancer Res. 2017;15:1551–7.
Gay LM, Kim S, Fedorchak K, et al. Comprehensive genomic profiling of esthesioneuroblastoma reveals additional treatment options. Oncologist. 2017;22:834–42.
Papadaki H, Kounelis S, Kapadia SB, Bakker A, Swalsky PA, Finkelstein SD. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma. Am J Surg Pathol. 1996;20:715–21.
Weiss GJ, Liang WS, Izatt T, et al. Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma. PLoS One. 2012;7:e37029.
Cohen ZR, Marmor E, Fuller GN, DeMonte F. Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus. 2002;12:e3.
Franchi A, Palomba A, Cardesa A. Current diagnostic strategies for undifferentiated tumours of the nasal cavities and paranasal sinuses. Histopathology. 2011;59:1034–45.
Thompson LD. Olfactory neuroblastoma. Head Neck Pathol. 2009;3:252–9.
Turri-Zanoni M, Maragliano R, Battaglia P, et al. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol. 2017;74:21.
Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2:683–90.
Platek ME, Merzianu M, Mashtare TL, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011;6:41.
Yin ZZ, Gao L, Luo JW, et al. Long-term outcomes of patients with esthesioneuroblastomas: a cohort from a single institution. Oral Oncol. 2016;53:48–53.
Harvey RJ, Nalavenkata S, Sacks R, et al. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma. Head Neck. 2017;39:2425–32.
Su SY, Bell D, Ferrarotto R, et al. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017;39:1671–9.
Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, Demonte F, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015;9:51–9.
Banuchi VE, Dooley L, Lee NY, et al. Patterns of regional and distant metastasis in esthesioneuroblastoma. Laryngoscope. 2016;126:1556–61.
Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma. Long term outcome and patterns of failure. The University of Virginia experience. Cancer. 1994;73:2556–62.
Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;37:1571–6.
Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32:706-15.
Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, Craft AW. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma study group. J Clin Oncol. 2000;18:3108–14.
Allam A, El-Husseiny G, Khafaga Y, et al. Ewing’s sarcoma of the head and neck: a retrospective analysis of 24 cases. Sarcoma. 1999;3:11–5.
Hafezi S, Seethala RR, Stelow EB, et al. Ewing’s family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol. 2011;5:8–16.
Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39:1267–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Franchi, A. (2020). Neuroectodermal and Melanocytic Tumors. In: Franchi, A. (eds) Pathology of Sinonasal Tumors and Tumor-Like Lesions. Springer, Cham. https://doi.org/10.1007/978-3-030-29848-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-29848-7_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29847-0
Online ISBN: 978-3-030-29848-7
eBook Packages: MedicineMedicine (R0)